000623 吉林敖东
已收盘 12-12 15:00:00
资讯
新帖
简况
吉林敖东：智能化驱动全产业链升级
证券之星 · 12-12 20:51
吉林敖东：智能化驱动全产业链升级
吉林敖东（000623）披露公司员工持股计划延期，12月5日股价上涨1.19%
证券之星 · 12-05
吉林敖东（000623）披露公司员工持股计划延期，12月5日股价上涨1.19%
吉林敖东：磷酸奥司他韦产销正常
证券之星 · 11-28
吉林敖东：磷酸奥司他韦产销正常
吉林敖东：安神补脑液获抗衰老及防治阿尔茨海默病专利
证券之星 · 11-28
吉林敖东：安神补脑液获抗衰老及防治阿尔茨海默病专利
吉林敖东（000623）披露补选独立董事公告，11月24日股价上涨0.58%
证券之星 · 11-24
吉林敖东（000623）披露补选独立董事公告，11月24日股价上涨0.58%
吉林敖东（000623）披露关于召开2025年第二次临时股东会的提示性公告，11月18日股价下跌0.59%
证券之星 · 11-18
吉林敖东（000623）披露关于召开2025年第二次临时股东会的提示性公告，11月18日股价下跌0.59%
吉林敖东（000623）披露关于公开发行可转换公司债券部分募集资金专户销户的公告，11月12日股价下跌0.71%
证券之星 · 11-12
吉林敖东（000623）披露关于公开发行可转换公司债券部分募集资金专户销户的公告，11月12日股价下跌0.71%
吉林敖东（000623）披露独立董事离任暨补选议案，11月06日股价上涨2.11%
证券之星 · 11-06
吉林敖东（000623）披露独立董事离任暨补选议案，11月06日股价上涨2.11%
吉林敖东：提名张春颖女士为公司第十一届董事会独立董事候选人
证券日报网 · 11-06
吉林敖东：提名张春颖女士为公司第十一届董事会独立董事候选人
股市必读：吉林敖东（000623）10月31日董秘有最新回复
证券之星 · 11-03
股市必读：吉林敖东（000623）10月31日董秘有最新回复
吉林敖东（000623）2025年三季报简析：净利润同比增长81.69%，盈利能力上升
证券之星 · 11-01
吉林敖东（000623）2025年三季报简析：净利润同比增长81.69%，盈利能力上升
图解吉林敖东三季报：第三季度单季净利润同比增长38.53%
证券之星 · 10-30
图解吉林敖东三季报：第三季度单季净利润同比增长38.53%
吉林敖东：持有广发证券20.0508%股权
证券之星 · 10-28
吉林敖东：持有广发证券20.0508%股权
吉林敖东：持有广发证券20.1149%股份
证券之星 · 10-22
吉林敖东：持有广发证券20.1149%股份
吉林敖东（000623）披露控股子公司获得药品补充申请通知书，10月20日股价上涨1.19%
证券之星 · 10-20
吉林敖东（000623）披露控股子公司获得药品补充申请通知书，10月20日股价上涨1.19%
吉林敖东：医药健康+金融资本双轮驱动发展模式
证券之星 · 10-18
吉林敖东：医药健康+金融资本双轮驱动发展模式
吉林敖东：持有广发证券H股2.77亿股
证券之星 · 10-15
吉林敖东：持有广发证券H股2.77亿股
吉林敖东：市值受多因素影响不完全反映内在价值
证券之星 · 10-14
吉林敖东：市值受多因素影响不完全反映内在价值
吉林敖东（000623）披露2025年中期分红派息实施公告，10月13日股价下跌1.44%
证券之星 · 10-13
吉林敖东（000623）披露2025年中期分红派息实施公告，10月13日股价下跌1.44%
吉林敖东：没有对沐曦股份进行投资
证券之星 · 10-10
吉林敖东：没有对沐曦股份进行投资
加载更多
公司概况
公司名称：
吉林敖东药业集团股份有限公司
所属行业：
医药制造业
上市日期：
1996-10-28
主营业务：
吉林敖东药业集团股份有限公司的主营业务是中药、化学药品研发、制造和销售。公司的主要产品是中药、化学药品、连锁药店批发、零售。凭借卓越的综合实力和行业影响力，公司连续十余年荣登中国制药工业百强榜单，2024中国中药研发实力排行榜TOP50中药榜第26位，并跻身“中国500最具价值品牌”，资产质量稳居行业前列。
发行价格：
7.20
{"stockData":{"symbol":"000623","market":"SZ","secType":"STK","nameCN":"吉林敖东","latestPrice":19.17,"timestamp":1765522998000,"preClose":19.1,"halted":0,"volume":10364002,"delay":0,"changeRate":0.0037,"floatShares":1191000000,"shares":1196000000,"eps":2.1472,"marketStatus":"已收盘","change":0.07,"latestTime":"12-12 15:00:00","open":19.18,"high":19.29,"low":19.03,"amount":199000000,"amplitude":0.0136,"askPrice":19.17,"askSize":155,"bidPrice":19.16,"bidSize":375,"shortable":0,"etf":0,"ttmEps":2.1472,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":19.1,"symbolType":"stock","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":21.01,"lowLimit":17.19,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1195895387,"isCdr":false,"pbRate":0.75,"roa":"--","peRate":8.927906,"roe":"7.56%","epsLYR":1.3179,"committee":0.289225,"marketValue":22925000000,"turnoverRate":0.0087,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-12-15。","floatMarketCap":22832000000},"requestUrl":"/m/hq/s/000623","defaultTab":"news","newsList":[{"id":"2590509859","title":"吉林敖东：智能化驱动全产业链升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2590509859","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590509859?lang=zh_cn&edition=full","pubTime":"2025-12-12 20:51","pubTimestamp":1765543900,"startTime":"0","endTime":"0","summary":"证券之星消息，吉林敖东12月11日在投资者关系平台上答复投资者关心的问题。我已经持有敖东十年以上了，是敖东的忠实粉丝。未来，公司将根据市场变化和经营需求，综合运用多种工具优化股东回报。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200037981.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0201","BK0239","BK0012","000623","BK0028","BK0086","BK0074"],"gpt_icon":0},{"id":"2589818011","title":"吉林敖东（000623）披露公司员工持股计划延期，12月5日股价上涨1.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589818011","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589818011?lang=zh_cn&edition=full","pubTime":"2025-12-05 22:23","pubTimestamp":1764944607,"startTime":"0","endTime":"0","summary":"截至2025年12月5日收盘，吉林敖东报收于19.49元，较前一交易日上涨1.19%，最新总市值为233.08亿元。近日，吉林敖东发布关于公司员工持股计划延期的公告。公告显示，公司于2025年12月5日召开第十一届董事会第二十二次会议，审议通过《关于公司员工持股计划延期的议案》，同意将公司第一期员工持股计划存续期延长12个月，即延长至2026年12月8日。本次延期经员工持股计划持有人代表大会审议通过，代表份额占总额的100%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500040469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0028","BK0012","BK0074","000623","BK0201","BK0086"],"gpt_icon":0},{"id":"2586735209","title":"吉林敖东：磷酸奥司他韦产销正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2586735209","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586735209?lang=zh_cn&edition=full","pubTime":"2025-11-28 15:21","pubTimestamp":1764314483,"startTime":"0","endTime":"0","summary":"证券之星消息，吉林敖东11月28日在投资者关系平台上答复投资者关心的问题。公司生产的磷酸奥司他韦胶囊当前产销正常，能够满足流感高发期的市场需求。其中，小儿柴桂退热口服液适用于儿童发热症状、感冒清热胶囊覆盖普通感冒需求、磷酸奥司他韦胶囊适用于病毒感冒，流感高发期间，公司通过全产业链布局保障产能，保障百姓用药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800016532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","000623","BK0074","BK0239","BK0012","BK0201","BK0086"],"gpt_icon":0},{"id":"2586209731","title":"吉林敖东：安神补脑液获抗衰老及防治阿尔茨海默病专利","url":"https://stock-news.laohu8.com/highlight/detail?id=2586209731","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586209731?lang=zh_cn&edition=full","pubTime":"2025-11-28 15:21","pubTimestamp":1764314483,"startTime":"0","endTime":"0","summary":"公司于2025年上半年获得《安神补脑液在制备治疗抗衰老药物中的应用》《安神补脑液在制备防治阿尔茨海默病药物中的应用》两项发明专利，标志着敖东牌安神补脑液从传统“安神助眠”向“抗衰老+防治阿尔茨海默病”疾病领域拓展。公司将持续推动安神补脑液在抗衰领域、防治阿尔茨海默病的临床价值转化，该产品升级路径清晰，依托科研与产业链优势抢占细分市场。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800016529.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000623","BK0086","BK0012","BK0188","BK0074","BK0028","BK0201","BK0239"],"gpt_icon":0},{"id":"2585460129","title":"吉林敖东（000623）披露补选独立董事公告，11月24日股价上涨0.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585460129","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585460129?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:13","pubTimestamp":1763993620,"startTime":"0","endTime":"0","summary":"截至2025年11月24日收盘，吉林敖东报收于19.02元，较前一交易日上涨0.58%，最新总市值为227.46亿元。该股当日开盘19.18元，最高19.19元，最低18.96元，成交额达2.47亿元，换手率为1.09%。公司近日发布公告称，吉林敖东药业集团股份有限公司于2025年11月24日召开2025年第二次临时股东会，审议通过《关于独立董事离任暨补选独立董事的议案》。议案获得出席会议股东所持表决权过半数通过，张春颖当选独立董事，任期至2026年7月17日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400035325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000623","BK0239","BK0086","BK0074","BK0028","BK0012","BK0201","BK0188"],"gpt_icon":0},{"id":"2584531509","title":"吉林敖东（000623）披露关于召开2025年第二次临时股东会的提示性公告，11月18日股价下跌0.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584531509","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584531509?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:12","pubTimestamp":1763475143,"startTime":"0","endTime":"0","summary":"截至2025年11月18日收盘，吉林敖东报收于20.26元，较前一交易日下跌0.59%，最新总市值为242.29亿元。该股当日开盘20.37元，最高20.56元，最低20.19元，成交额达2.67亿元，换手率为1.1%。公司近日发布公告称，吉林敖东药业集团股份有限公司将于2025年11月24日召开2025年第二次临时股东会，会议采取现场投票与网络投票相结合的方式。登记时间为2025年11月20日，地点为公司董事会办公室。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800039680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0012","BK0074","BK0239","000623","BK0201","BK0028","BK0086"],"gpt_icon":0},{"id":"2582720553","title":"吉林敖东（000623）披露关于公开发行可转换公司债券部分募集资金专户销户的公告，11月12日股价下跌0.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582720553","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582720553?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:12","pubTimestamp":1762956749,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘，吉林敖东报收于21.05元，较前一交易日下跌0.71%，最新总市值为251.74亿元。该股当日开盘21.26元，最高21.33元，最低20.94元，成交额达2.44亿元，换手率为0.97%。公司近日发布公告称，吉林敖东药业集团股份有限公司因2018年公开发行可转换公司债券的募投项目全部结项，节余募集资金已永久补充流动资金，相关募集资金专户余额清零或已转出，现办理部分募集资金专户注销手续。注销后，公司仍保留两个专户用于支付剩余合同款项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200041178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0012","BK0201","BK0074","BK0086","BK0188","000623"],"gpt_icon":0},{"id":"2581091246","title":"吉林敖东（000623）披露独立董事离任暨补选议案，11月06日股价上涨2.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581091246","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581091246?lang=zh_cn&edition=full","pubTime":"2025-11-06 22:20","pubTimestamp":1762438835,"startTime":"0","endTime":"0","summary":"截至2025年11月6日收盘，吉林敖东报收于21.34元，较前一交易日上涨2.11%，最新总市值为255.2亿元。公司近日发布公告称，吉林敖东药业集团股份有限公司于2025年11月6日召开第十一届董事会第二十次会议，会议应到董事9名，实际参会9名，会议由董事长李秀林主持，符合法律法规和公司章程规定。公司将于2025年11月24日召开第二次临时股东大会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110600038188.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0188","BK0201","BK0028","000623","BK0239","BK0074","BK0012"],"gpt_icon":0},{"id":"2581067099","title":"吉林敖东：提名张春颖女士为公司第十一届董事会独立董事候选人","url":"https://stock-news.laohu8.com/highlight/detail?id=2581067099","media":"证券日报网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581067099?lang=zh_cn&edition=full","pubTime":"2025-11-06 21:39","pubTimestamp":1762436340,"startTime":"0","endTime":"0","summary":"证券日报网讯11月6日晚间，吉林敖东发布公告称，同意提名张春颖女士为公司第十一届董事会独立董事候选人。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-06/doc-infwnsqu6814749.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-06/doc-infwnsqu6814749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0074","BK0012","000623","BK0239","BK0028","BK0086","BK0188","BK0201"],"gpt_icon":0},{"id":"2580236904","title":"股市必读：吉林敖东（000623）10月31日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2580236904","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580236904?lang=zh_cn&edition=full","pubTime":"2025-11-03 04:45","pubTimestamp":1762116312,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，吉林敖东报收于21.48元，下跌0.51%，换手率1.96%，成交量23.31万手，成交额5.04亿元。关于2025年第三季度业绩及利润分配的具体情况，请您查阅公司于2025年10月31日发布的《2025年第三季度报告》。当日关注点来自交易信息汇总：10月31日主力资金净流入1148.56万元，占总成交额2.28%。交易信息汇总资金流向10月31日主力资金净流入1148.56万元，占总成交额2.28%；游资资金净流入780.58万元，占总成交额1.55%；散户资金净流出1929.14万元，占总成交额3.83%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300000985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000623","BK0086","BK0201","BK0012","BK0028","BK0188","BK0074"],"gpt_icon":0},{"id":"2580941275","title":"吉林敖东（000623）2025年三季报简析：净利润同比增长81.69%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2580941275","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580941275?lang=zh_cn&edition=full","pubTime":"2025-11-01 06:35","pubTimestamp":1761950140,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期吉林敖东发布2025年三季报。截至本报告期末，公司营业总收入16.4亿元，同比下降14.1%，归母净利润22.6亿元，同比上升81.69%。按单季度数据看，第三季度营业总收入5.14亿元，同比上升3.25%，第三季度归母净利润9.79亿元，同比上升38.53%。本报告期吉林敖东盈利能力上升，毛利率同比增幅20.17%，净利率同比增幅115.46%。然而去年的净利率为58.19%，算上全部成本后，公司产品或服务的附加值极高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110100007180.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000623"],"gpt_icon":0},{"id":"2579961145","title":"图解吉林敖东三季报：第三季度单季净利润同比增长38.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579961145","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579961145?lang=zh_cn&edition=full","pubTime":"2025-10-30 19:51","pubTimestamp":1761825112,"startTime":"0","endTime":"0","summary":"证券之星消息，吉林敖东2025年三季报显示，前三季度公司主营收入16.4亿元，同比下降14.1%；归母净利润22.6亿元，同比上升81.69%；扣非净利润19.9亿元，同比上升65.2%；其中2025年第三季度，公司单季度主营收入5.14亿元，同比上升3.25%；单季度归母净利润9.79亿元，同比上升38.53%；单季度扣非净利润8.23亿元，同比上升109.71%；负债率10.87%，投资收益20.81亿元，财务费用2963.16万元，毛利率47.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000040371.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000623"],"gpt_icon":0},{"id":"2578603764","title":"吉林敖东：持有广发证券20.0508%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2578603764","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578603764?lang=zh_cn&edition=full","pubTime":"2025-10-28 08:33","pubTimestamp":1761611589,"startTime":"0","endTime":"0","summary":"投资者提问：咱们公司占广发证券20.11%的股权。2024年广发证券净利润105.4亿元，咱们公司年报显示“对联营企业和合营企业的投资收益”17.45亿元，只占到了广发证券净利润的16.56%。截至2024年12月31日，公司及全资子公司合计持有广发证券1,528,087,767股，占广发证券总股本的20.0508%。广发证券2024年实现归属于上市公司股东的净利润963,682.99万元，公司对广发证券的投资收益为174,940.45万元，比上年同期124,343.52万元，同比增长40.69%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800009674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","LU1979443071.USD","BK0012","BK1147","BK0028","BK0183","000776","BK0074","BK0201","BK0276","BK1564","LU1934453819.USD","SG9999001093.SGD","01776","BK0188","BK0086","000623"],"gpt_icon":0},{"id":"2577353311","title":"吉林敖东：持有广发证券20.1149%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2577353311","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577353311?lang=zh_cn&edition=full","pubTime":"2025-10-22 15:18","pubTimestamp":1761117494,"startTime":"0","endTime":"0","summary":"公司及子公司持有的广发证券股权全部采用权益法作为长期股权投资核算。截至目前，公司持有广发证券境内上市内资股（A股）股份1,252,768,767股、境外上市外资股（H股）股份240,274,200股，以上持股占广发证券总股本的19.6302%；公司全资子公司敖东国际（香港）实业有限公司持有广发证券境外上市外资股（H股）股份36,868,800股，占广发证券总股本的0.4847%。公司及全资子公司合计持有广发证券1,529,911,767股，占广发证券总股本的20.1149%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200018366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0276","BK0183","000623","BK0086","SG9999001093.SGD","BK0012","LU1979443071.USD","01776","BK1564","BK0188","000776","BK0028","BK0074","BK0201","BK0239","LU1934453819.USD","BK1147"],"gpt_icon":0},{"id":"2576681688","title":"吉林敖东（000623）披露控股子公司获得药品补充申请通知书，10月20日股价上涨1.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576681688","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576681688?lang=zh_cn&edition=full","pubTime":"2025-10-20 22:23","pubTimestamp":1760970192,"startTime":"0","endTime":"0","summary":"截至2025年10月20日收盘，吉林敖东报收于20.47元，较前一交易日上涨1.19%，最新总市值为244.8亿元。该股当日开盘20.71元，最高20.77元，最低20.31元，成交额达3.09亿元，换手率为1.26%。公司近日发布公告称，其控股子公司吉林敖东药业集团延吉股份有限公司收到国家药品监督管理局下发的“盐酸纳洛酮注射液”《药品补充申请批准通知书》。盐酸纳洛酮注射液通用名称为盐酸纳洛酮注射液，剂型为注射剂，规格为1ml：0.4mg，包装规格为10支/盒，有效期18个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000032348.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","000623","BK0074","BK0239","BK0086","BK0201","BK0012","BK0028"],"gpt_icon":0},{"id":"2576606920","title":"吉林敖东：医药健康+金融资本双轮驱动发展模式","url":"https://stock-news.laohu8.com/highlight/detail?id=2576606920","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576606920?lang=zh_cn&edition=full","pubTime":"2025-10-18 07:00","pubTimestamp":1760742041,"startTime":"0","endTime":"0","summary":"证券之星消息，吉林敖东10月18日在投资者关系平台上答复投资者关心的问题。公司营收与净利润增长不同步，反映了公司独特的“医药健康+金融资本”双轮驱动发展模式的特点。营业收入主要反映医药主业的经营成果，受行业政策及产品结构优化影响，短期承压。“医药健康+金融资本”双轮驱动发展模式能够持续为公司提供充沛的现金流，有效反哺医药研发、抵御行业波动，支撑公司高质量发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101800004803.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0188","BK0086","BK0074","000623","BK0012","BK0028","BK0239"],"gpt_icon":0},{"id":"2575787653","title":"吉林敖东：持有广发证券H股2.77亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=2575787653","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575787653?lang=zh_cn&edition=full","pubTime":"2025-10-15 20:51","pubTimestamp":1760532683,"startTime":"0","endTime":"0","summary":"投资者提问：网传公司在2020年至2024年间均价在10.5港元/股以下增持了广发证券H股1.19.亿股，请问是否属实？公司及全资子公司合计持有广发证券境外上市外资股（H股）股份277,143,000股，根据投资测算持股均价约为人民币9.94元/股，具体数据可详见公司定期报告中披露的相关信息。广发证券是公司长期持有的核心优质资产，目前公司未制定减持计划。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101500036510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0276","BK1147","LU1934453819.USD","BK0086","BK1564","LU1979443071.USD","BK0183","BK0188","BK0028","000623","000776","BK0074","BK0012","BK0239","BK0201","SG9999001093.SGD","01776"],"gpt_icon":0},{"id":"2575696261","title":"吉林敖东：市值受多因素影响不完全反映内在价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2575696261","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575696261?lang=zh_cn&edition=full","pubTime":"2025-10-14 15:48","pubTimestamp":1760428095,"startTime":"0","endTime":"0","summary":"证券之星消息，吉林敖东10月14日在投资者关系平台上答复投资者关心的问题。投资者提问：公司回答投资者：公司及全资子公司目前持有广发证券市值合计已有357亿。此市值还未含公司另持有的几十亿其他上市公司股票。公司总市值会受到宏观经济、行业周期、市场情绪、流动性环境等多方面因素的影响，并不能完全反映企业的长期内在价值和资产质量。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101400048532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0086","BK0012","000623","BK0074","BK0188","BK0201","BK0239"],"gpt_icon":0},{"id":"2575400913","title":"吉林敖东（000623）披露2025年中期分红派息实施公告，10月13日股价下跌1.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575400913","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575400913?lang=zh_cn&edition=full","pubTime":"2025-10-13 22:44","pubTimestamp":1760366668,"startTime":"0","endTime":"0","summary":"截至2025年10月13日收盘，吉林敖东报收于20.53元，较前一交易日下跌1.44%，最新总市值为245.52亿元。该股当日开盘20.2元，最高20.59元，最低20.05元，成交额达5.36亿元，换手率为2.22%。公司近日发布公告称，将实施2025年中期分红派息方案。本次权益分派不送红股，不进行资本公积金转增股本。股权登记日为2025年10月21日，除权除息日为2025年10月22日。除权除息价格按股权登记日收盘价减0.1960675元/股确定。本次分配方案与股东大会审议通过的一致，且在规定时间内实施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300025527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0086","000623","BK0012","BK0028","BK0201","BK0074","BK0239"],"gpt_icon":0},{"id":"2574126770","title":"吉林敖东：没有对沐曦股份进行投资","url":"https://stock-news.laohu8.com/highlight/detail?id=2574126770","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574126770?lang=zh_cn&edition=full","pubTime":"2025-10-10 17:03","pubTimestamp":1760086998,"startTime":"0","endTime":"0","summary":"证券之星消息，吉林敖东10月10日在投资者关系平台上答复投资者关心的问题。公司及公司参与的设立的基金，没有对沐曦股份进行投资。公司如有重大的对外投资事项，将严格按照有关规定履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101000025812.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0074","BK0188","BK0086","000623","BK0201","BK0239","BK0012","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765695562930,"stockEarnings":[{"period":"1week","weight":-0.0164},{"period":"1month","weight":-0.0893},{"period":"3month","weight":0.0007},{"period":"6month","weight":0.1833},{"period":"1year","weight":0.0485},{"period":"ytd","weight":0.1402}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"吉林敖东药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"61216人(较上一季度减少7.18%)","perCapita":"19456股","listingDate":"1996-10-28","address":"吉林省延边朝鲜族自治州敦化市敖东大街2158号","registeredCapital":"119589万元","survey":" 吉林敖东药业集团股份有限公司的主营业务是中药、化学药品研发、制造和销售。公司的主要产品是中药、化学药品、连锁药店批发、零售。凭借卓越的综合实力和行业影响力，公司连续十余年荣登中国制药工业百强榜单，2024中国中药研发实力排行榜TOP50中药榜第26位，并跻身“中国500最具价值品牌”，资产质量稳居行业前列。","listedPrice":7.2},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"吉林敖东(000623)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供吉林敖东(000623)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"吉林敖东,000623,吉林敖东股票,吉林敖东股票老虎,吉林敖东股票老虎国际,吉林敖东行情,吉林敖东股票行情,吉林敖东股价,吉林敖东股市,吉林敖东股票价格,吉林敖东股票交易,吉林敖东股票购买,吉林敖东股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"吉林敖东(000623)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供吉林敖东(000623)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}